| abstract |
Use of a D3 dopamine receptor antagonist for the preparation of a medicament for the treatment of renal impairment. The use wherein the receptor antagonist is 5-amino-3- (4- (4- (2-tert-butyl-6-trifluoromethyl) pyrimidin-4-yl) -piperazin-1-yl) -2-methyl-but -2-en-1-yl-mercapto) -4-methyl-1,2,4- (4H) -triazole or 2- (3- (4- (2-tert-butyl-6-trifluoromethyl) pyrimidine) fumarate -4-yl) piperazin-1-yl) propyl mercaptopyrimidin-4-ol. |